Effects of the interrelationship between dietary protein and minerals on tissue content of trace metals in streptozotocin-diabetic rats. 1984

W T Johnson, and G W Evans

Zinc, iron and copper concentrations were measured in several organs from streptozotocin-diabetic and normal male, Long-Evans rats that were maintained for 21 days on a dietary regimen designed to study the combined or singular effects of insulin-dependent diabetes, dietary protein and dietary minerals on the tissue content of trace metals. The diets contained either 20 ppm zinc and iron, 5 ppm copper and 20% protein (HMHP); 8 ppm zinc and iron, 2 ppm copper and 8.3% protein (LMLP); 20 ppm zinc and iron, 5 ppm copper and 8.3% protein (HMLP) or 8 ppm zinc and iron, 2 ppm copper and 20% protein (LMHP). The concentrations of zinc, iron and copper in liver, zinc and iron in kidney and iron in femur were elevated in the diabetic rats and were not influenced by dietary protein and mineral interaction. However, dietary protein, mineral or protein X mineral interaction significantly affected trace metal concentrations of several organs in diabetic rats but had no significant effect in normal rats. Specifically, copper concentration in kidney and duodenum of diabetic rats were influenced by protein X mineral interaction, duodenal zinc concentrations were higher in diabetic rats fed high mineral diets (HMHP and HMLP) compared to diabetic rats fed low mineral diets (LMHP and LMLP) and femur zinc concentration was higher in diabetic rats fed high protein diets (HMHP and LMLP) compared to diabetic rats fed low protein diets (HMLP and LMLP). While hepatic picolinic carboxylase was elevated severalfold in diabetic rats, it was highest in the diabetic rats fed high protein diets (HPHM and HPLM) suggesting that picolinic acid may, at least in part, mediate the effects of dietary protein and minerals on tissue trace metal concentrations in diabetic rats.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008297 Male Males
D002262 Carboxy-Lyases Enzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1. Carboxy-Lyase,Decarboxylase,Decarboxylases,Carboxy Lyase,Carboxy Lyases
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004044 Dietary Proteins Proteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS. Proteins, Dietary,Dietary Protein,Protein, Dietary
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

W T Johnson, and G W Evans
January 1989, Kidney international,
W T Johnson, and G W Evans
July 2012, Acta pharmacologica Sinica,
W T Johnson, and G W Evans
June 1979, The Journal of nutrition,
W T Johnson, and G W Evans
January 1995, Voprosy pitaniia,
W T Johnson, and G W Evans
May 1985, The Journal of nutrition,
W T Johnson, and G W Evans
January 1988, British journal of pharmacology,
Copied contents to your clipboard!